Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

Conditions: Leukemia, Lymphocytic, Chronic, B-Cell Interventions: Behavioral: Individual Physical Activity Intervention (IPAI); Drug: Ibrutinib Sponsors: Janssen Cilag S.A.S. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials